Stifel Maintains Hold on Edwards Lifesciences, Raises Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Hold rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $83 to $85.
April 26, 2024 | 3:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stifel analyst Rick Wise maintains a Hold rating on Edwards Lifesciences and raises the price target from $83 to $85.
The increase in price target by Stifel suggests a positive outlook on Edwards Lifesciences' stock, potentially leading to increased investor confidence and a short-term positive impact on the stock price. The Hold rating indicates that the stock is currently valued appropriately, but the raised target suggests some upside potential.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100